Cellipont Bioservices

Cellipont Bioservices company information, Employees & Contact Information

Cellipont Bioservices is a cell therapy CDMO in the development and small-to-large batch manufacturing of cell therapies. Our leaders have played an instrumental role in shaping cell therapy development and manufacturing methods and technologies, and our technically-strong team has been recognized by customers and technology partners for its ability to productively grow challenging cells. Cellipont is driven to help our clients to expand patient access to life-changing medicines through best-in-class development, analytical and manufacturing capabilities.   We are a small company with a culture that is extremely responsive and customer-centric. Despite our size, Cellipont Bioservices has very deep technical experience, including 18,000+ tissue samples and more than 900 primary cell cultures. With decades of experience at advanced therapy service companies large and small, our leadership team is guiding Cellipont’s growth with deep knowledge of what it takes succeed in this space.   Cellipont Bioservices facilities and quality systems are GMP-compliant. We have extensive experience in multiple product areas, including CAR-T, iNK, dendritic cell, & other novel cell therapy approaches. OUR NAME: By combining “cell” with the latin root for bridge (pont), the name Cellipont Bioservices reflects several dimensions of what we are all about: we bridge our innovator clients with patients; we bridge technical excellence and personal service; and for our team, we bridge personal passion with professional vocation. As we finalize our corporate rebranding, we look forward to launching a new website in the coming weeks to better share our vision with you.
Looking for a particular Cellipont Bioservices employee's phone or email?

Cellipont Bioservices Questions

News

Cellipont Bioservices and CellVax Therapeutics Expand Partnership to Advance cGMP Manufacturing of Personalized Immunotherapy FK-GI101 for GI Cancers - PR Newswire

Cellipont Bioservices and CellVax Therapeutics Expand Partnership to Advance cGMP Manufacturing of Personalized Immunotherapy FK-GI101 for GI Cancers PR Newswire

Marker Therapeutics Announces Collaboration with Cellipont Bioservices for cGMP Manufacturing of MT-601 T Cell Therapy - Nasdaq

Marker Therapeutics Announces Collaboration with Cellipont Bioservices for cGMP Manufacturing of MT-601 T Cell Therapy Nasdaq

Marker Therapeutics and Cellipont Bioservices Announce Collaboration to Advance cGMP Manufacturing of MT-601, a Multi-Antigen Recognizing T Cell Therapy for Patients with Lymphoma - GlobeNewswire

Marker Therapeutics and Cellipont Bioservices Announce Collaboration to Advance cGMP Manufacturing of MT-601, a Multi-Antigen Recognizing T Cell Therapy for Patients with Lymphoma GlobeNewswire

Bionique Testing Laboratories and Cellipont Bioservices Partner to Accelerate Adoption of Rapid Mycoplasma Testing in Cell and Gene Therapy Manufacturing - PR Newswire

Bionique Testing Laboratories and Cellipont Bioservices Partner to Accelerate Adoption of Rapid Mycoplasma Testing in Cell and Gene Therapy Manufacturing PR Newswire

Cellipont Bioservices Appoints Darren Head As Chief Executive Officer - citybiz

Cellipont Bioservices Appoints Darren Head As Chief Executive Officer citybiz

Cellipont Bioservices and Optieum Biotechnologies Partner to Advance cGMP Manufacturing of Groundbreaking CAR-T Therapy for Glioblastoma - PR Newswire

Cellipont Bioservices and Optieum Biotechnologies Partner to Advance cGMP Manufacturing of Groundbreaking CAR-T Therapy for Glioblastoma PR Newswire

Cellipont Receives Strategic Debt Investment from OrbiMed to Complete State-of-the-Art Commercial Manufacturing Facility - Business Wire

Cellipont Receives Strategic Debt Investment from OrbiMed to Complete State-of-the-Art Commercial Manufacturing Facility Business Wire

Cellipont Bioservices and Secretome Therapeutics Partner for cGMP Manufacturing for Master Cell Bank for Lead Asset STM-01 - PR Newswire

Cellipont Bioservices and Secretome Therapeutics Partner for cGMP Manufacturing for Master Cell Bank for Lead Asset STM-01 PR Newswire

Cellipont Bioservices and Xiogenix Announce Strategic Partnership to Enhance Client Access to Advanced Filling Systems - PR Newswire

Cellipont Bioservices and Xiogenix Announce Strategic Partnership to Enhance Client Access to Advanced Filling Systems PR Newswire

Cellipont Bioservices Announces Grand Opening of Its Purpose-built Cell Therapy Manufacturing Facility - PR Newswire

Cellipont Bioservices Announces Grand Opening of Its Purpose-built Cell Therapy Manufacturing Facility PR Newswire

Cellipont Bioservices and Wugen Sign Agreement for the Clinical Manufacture of Wugen's Off-the-shelf CAR-T Cellular Therapies - PR Newswire

Cellipont Bioservices and Wugen Sign Agreement for the Clinical Manufacture of Wugen's Off-the-shelf CAR-T Cellular Therapies PR Newswire

Cellipont Bioservices and Adva Biotechnology Collaborate to Optimize Cell Therapy Manufacturing with the ADVA X3® Platform - PR Newswire

Cellipont Bioservices and Adva Biotechnology Collaborate to Optimize Cell Therapy Manufacturing with the ADVA X3® Platform PR Newswire

Cellipont Bioservices and Diakonos Oncology Corporation Collaborate to Develop Groundbreaking Therapy for Glioblastoma - PR Newswire

Cellipont Bioservices and Diakonos Oncology Corporation Collaborate to Develop Groundbreaking Therapy for Glioblastoma PR Newswire

Cellipont Bioservices and Evia Bio Collaborate to Launch Cryo Excellence Center (CryoX) in Houston, TX - PR Newswire

Cellipont Bioservices and Evia Bio Collaborate to Launch Cryo Excellence Center (CryoX) in Houston, TX PR Newswire

Top Cellipont Bioservices Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant